Deep venous thrombosis is a known complication of thrombotic states and disorders associated with sluggish systemic circulation, common sites being pelvic or lower limb veins. Involvement of the upper limb veins is rarel, but superior vena caval thrombosis and jugular vein thrombosis have been reported in dilated cardiomyopathy (DCM)2.
CASE HISTORIES
Case I A 27-year-old Omani with alcoholic dilated cardiomyopathy was admitted with exacerbation of cardiac failure. He improved when treated with frusemide, captopril and digoxin but two weeks later developed pain and swelling of the right upper arm and the right side of the neck. The arm was tender with bluish discoloration and distended veins at the root of neck and over the right shoulder. He was well hydrated and the lower limbs were normal. He did not have any central venous cannulation and there was no evidence of superficial thrombophlebitis. The clinical diagnosis was spontaneous deep vein thrombosis (DVT) involving the right axillary and subclavian veins. Compression ulrasono-graphy, colour flow doppler evaluation and a technetium-99m scan ( Figure 1 ) confirmed extensive thrombosis of the right brachial vein, extending to the right axillary, subclavian and internal jugular veins. He was in sinus rhythm and an echocardiogram excluded intracardiac thrombus. Values for prothrombin time, activated partial thromboplastin time, protein C and protein S (functional assay), antithrombin III, plasminogen and plasminogen activator were all normal. Alpha-2 antiplasmin and plasminogen activator inhibitor were also normal and lupus anticoagulant was negative. Modified activated protein C resistance ratio was normal. The patient was anticoagulated with heparin and maintained on warfarin to keep the international normalized ratio between 2.0 and 2.5. In the 4 years since the first episode of DVT he has remained generally well but has had mild episodes of DVT when anticoagulant control was unsatisfactory.
Case 2
An 8-year-old Omani girl with post-myocarditis dilated cardiomyopathy was admitted in heart failure. She improved on treatment with frusemide and digoxin but Factor V (Leiden) has now been identified as an important cause of hypercoagulability and is present in 18% of caucasian patients with venous thrombosis5. Both our patients were screened for factor V (Leiden) with the modified activated protein C resistance ratio and had normal values. 75 Omani patients with various thrombotic disorders and 150 normal Omani controls have been screened for factor V (Leiden) in this way and none has so far been found to have a low ratio (personal communication, Haematology Department, Sultan Qaboos University Hospital).
The prothrombin gene variant 2021 OA has recently been implicated in thrombotic states. DNA analysis for this variant was not available; however, this gene mutation is extremely rare in non-caucasians6 7.
